1. Home
  2. Analysis
  3. Ritonavir
  4. Parkinson-s-disease

Ritonavir and Parkinson's disease - a phase IV clinical study of FDA data

Summary:

Parkinson's disease is reported as a side effect among people who take Ritonavir (ritonavir), especially for people who are female, 40-49 old, also take Darunavir, and have Hiv infection.

The phase IV clinical study analyzes which people have Parkinson's disease when taking Ritonavir. It is created by eHealthMe based on reports of 13,026 people who have side effects when taking Ritonavir from the FDA, and is updated regularly.

What is Ritonavir?

Ritonavir has active ingredients of ritonavir. eHealthMe is studying from 13,036 Ritonavir users. Check the latest studies of Ritonavir.

What is Parkinson's disease?

Parkinson's disease is found to be associated with 1,116 drugs and 1,625 conditions by eHealthMe. Check the latest studies of Parkinson's disease.

On Jul, 15, 2026

13,026 people reported to have side effects when taking Ritonavir.
Among them, 16 people (0.12%) have Parkinson's disease.

Could Ritonavir cause Parkinson's disease?

Among these 16 people:

What is the gender of people who have Parkinson's disease when taking Ritonavir? *

  • female: 92.31 %
  • male: 7.69 %

What is the age of people who have Parkinson's disease when taking Ritonavir? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 91.67 %
  • 50-59: 8.33 %
  • 60+: 0.0 %

What are other drugs people take besides Ritonavir? *

  1. Darunavir: 14 people, 87.50%
  2. Maraviroc: 13 people, 81.25%
  3. Zidovudine: 1 person, 6.25%
  4. Truvada: 1 person, 6.25%
  5. Nifedipine: 1 person, 6.25%
  6. Lyrica: 1 person, 6.25%
  7. Lexapro: 1 person, 6.25%
  8. Lamivudine: 1 person, 6.25%
  9. Emtricitabine: 1 person, 6.25%
  10. Efavirenz: 1 person, 6.25%

What are other side effects people have besides Parkinson's disease? *

  1. Csf Test Abnormal: 13 people, 81.25%
  2. Viral Load Increased: 9 people, 56.25%
  3. Drug Ineffective: 9 people, 56.25%
  4. Neurological Symptom (symptoms of nervous system disease): 9 people, 56.25%
  5. Loss Of Consciousness: 1 person, 6.25%
  6. Disturbance In Attention: 1 person, 6.25%
  7. Feeling Abnormal: 1 person, 6.25%
  8. Gait Disturbance: 1 person, 6.25%
  9. Hypoaesthesia (reduced sense of touch or sensation): 1 person, 6.25%
  10. Judgement Impaired: 1 person, 6.25%

What are the existing conditions these people have? *

  1. Hiv Infection: 16 people, 100.00%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ritonavir and have Parkinson's disease?

- Check whether Parkinson's disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ritonavir:

Parkinson's disease treatments and more:

How severe was Parkinson's disease and when was it recovered:

Expand to all the drugs that have ingredients of ritonavir:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ritonavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Parkinson's disease:

Browse all the conditions that are associated with Parkinson's disease:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ritonavir (the active ingredients of Ritonavir) and Ritonavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.